Nadim Akhtar

Impurities in Oligonucleotide Drug Substances and Drug Products.

S. Henry, A. Teasdale, J. Foy, 2017, Nucleic acid therapeutics.

The global characterisation of a drug-dendrimer conjugate - PEGylated poly-lysine dendrimer.

D. Buttar, Tony W. T. Bristow, N. Mahmoudi, 2022, Journal of pharmaceutical sciences.

Highway to Success—Developing Advanced Polymer Therapeutics

M. Ashford, Richard M. England, Nadim Akhtar, 2021, Advanced Therapeutics.

Evaluation of particle size techniques to support the development of manufacturing scale nanoparticles for application in pharmaceuticals.

C. Minelli, S. Wren, Yiwen Pei, 2020, Journal of pharmaceutical sciences.

Considerations for the Terminal Sterilization of Oligonucleotide Drug Products.

Daniel P Decollibus, C. Lindenberg, G. Govindan, 2023, Nucleic acid therapeutics.

In depth characterization of physicochemical critical quality attributes of a clinical drug-dendrimer conjugate

F. Caputo, L. Calzolai, M. Jayne Lawrence, 2023, International journal of pharmaceutics.

Determination of Purge Factors for Use in Oligonucleotide Control Strategies

Tobias Vandermeersch, S. Breitler, Jessica A. Stolee, 2022, Organic Process Research & Development.

Impurities in Oligonucleotide Drug Substances and Drug Products.

S. Henry, A. Teasdale, J. Foy, 2017, Nucleic acid therapeutics.